z-logo
open-access-imgOpen Access
Semaglutide in Overweight and Obese patients: Cardiovascular and/or Renal Metabolic Benefits
Author(s) -
Jorge Rico-Fontalvo,
Rodrigo Daza-Arnedo,
Jose Rafael Cabrales Juan,
Juan Montejo-Hernández
Publication year - 2022
Publication title -
revista colombiana de nefrología
Language(s) - English
Resource type - Journals
eISSN - 2500-5006
pISSN - 2389-7708
DOI - 10.22265/acnef.9.3.614
Subject(s) - semaglutide , medicine , albuminuria , overweight , diabetes mellitus , placebo , population , type 2 diabetes , obesity , urology , endocrinology , liraglutide , environmental health , alternative medicine , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom